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Background. Biliary cystadenomas (BCAs) are rare, benign, potentially malignant cystic lesions of the liver, accounting for less than
5% of cystic liver tumours.We report the outcome following resection of biliary cystadenoma from a single tertiary centre.Methods.
Data of patients who had resection of BCA between January 1993 and July 2014 were obtained from liver surgical database. Patient
demographics, clinicopathological characteristics, operative data, and postoperative outcome were analysed. Results. 29 patients
had surgery for BCA. Male : female ratio was 1 : 28. Clinical presentation was abdominal pain (74%), jaundice (20%), abdominal
mass (14%), and deranged liver function tests (3%). Cyst characteristics included septations (48%), wall thickening (31%), wall
irregularity (38%), papillary projections (10%), andmural nodule (3%). Surgical procedures included atypical liver resection (52%),
left hemihepatectomy (34%), right hemihepatectomy (10%), and left lateral segmentectomy (3%). Median length of stay was 7 (IQ
6.5–8.5) days. Two patients developed postoperative bile leak. No patients hadmalignancy on final histology.Median follow-up was
13 (IQ 6.5–15.7) years. One patient developed delayed biliary stricture and one died of cholangiocarcinoma 11 years later.Conclusion.
Biliary cystadenomas can be resected safely with significantly low morbidity. Malignant transformation and recurrence are rare.
Complete surgical resection provides a cure.
1. Introduction
Biliary cystadenomas (BCAs) are rare, benign, but potentially
malignant unilocular or multilocular cystic lesions of the
biliary system occurring most commonly in women [1–5]. It
commonly arises from the liver, but BCAs of extra hepatic
biliary tract and gall bladder have been reported [2, 6–9].
BCAs account for approximately 5% of all hepatic cystic
lesions [10].
First publication on BCA was in 1887 and the first resec-
tion was performed in 1892 [11]. With the widespread avail-
ability of modern imaging techniques and developments in
safe liver surgery, the number of reported cases increased in
1990s [12]. Diagnosis of BCA was complicated by the pres-
ence of wide variety of cystic lesions in the liver, including
simple cysts, parasitic cysts, degenerated metastatic tum-
ours, mucin-producing metastatic tumours, congenital cys-
tic dilatations, cystic hemangioma, lymphangioma, hepatic
foregut cysts, mesenchymal hamartoma, and teratoma [5, 13–
15].
Due to its premalignant nature and lack of reliability of
imaging and preoperative aspiration cytology in differentiat-
ing BCA from cystadenocarcinoma, all lesions suspected of
BCA should be surgically removed with negativemargin [14–
21]. We aim to describe and analyse the outcome following
resection of BCA from a single tertiary centre.
2. Methods
A retrospective analysis of all patients who had resection
of BCA was carried out from a prospectively maintained
liver surgical and pathological database over a period of 21
years (January 1993 to July 2014). Patients’ demographics,
clinical presentation, preoperative imaging, operative data
and postoperative outcome were analysed. Cystic lesions of
the liver were evaluated with ultrasound scan, CT scan,
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and MRI liver (in selected cases). Cyst characteristics were
analysed with respect to number of cysts (single/multiple),
locularity (unilocular or multilocular), presence of cyst wall
thickening, irregularity, papillary projections, and mural
nodule. Cystic lesions showing wall thickening, irregularity,
internal septations, presence of nodules, papillary projec-
tions, and communication with biliary system were offered
surgical resection. Nonanatomical/segmental resection was
performed if feasible, but large BCAs and lesions confined
to few segments were treated with formal right or left
hepatectomy or left lateral segmentectomy. Postoperative
complications were recorded according to Dindo et al.
classification [22]. Histopathological information regarding
completeness of excision, resection margin, and evidence
of dysplasia/malignancy were collated. Patients who had
partial excision of cyst wall for suspected simple cyst and
subsequently found to have BCA were subjected to formal
resection. All patients were followed up in the clinic within 6
weeks of surgery and were reviewed in the clinic if necessary
thereafter. Patients latest follow-up details were collected
from the hospital based computer system and where there
was no information available, patient’s general practitioners
were contacted regarding patients current clinical status.
3. Statistical Analysis
Continuous variables were presented as median with inter-
quartile range and the categorical variables were presented
in percentages. Survival was calculated using Kaplan-Meier
method. SPSS version 22.0 (SPSS, Chicago, IL) was used to
perform statistical analysis.
4. Results
187 patients with cystic liver lesions underwent surgery
during the study period. Of these, 29 patients were found
to have BCA. Median age was 62 (IQ 48–74) years and
all were women except one. The main clinical presentation
was abdominal pain (74%) followed by jaundice (20%),
abdominal mass (14%), and deranged liver function tests
(LFTs) (3%). Patients who presented with deranged LFTs
mainly had elevated transaminases with normal bilirubin.
One patient was incidentally found to have a cystic lesion
in the liver on ultrasound scan performed for irritable bowel
syndrome like symptoms.
On preoperative imaging, single cyst was seen inmajority
of the patients (76%). Approximately half of the cysts were
unilocular (𝑛 = 15). Cysts were centrally located in 48% of
the cases. Cyst characteristics were as follows: wall thickening
(31%), wall irregularity (38%), papillary projections (10%),
and mural nodule (3%). Twenty-six (89%) patients were
suspected of having BCA on preoperative imaging while the
remaining 3 patientswere suspected to have simple liver cysts.
None of the patients had preoperative cyst fluid cytology, as
we believe that negative result will not preclude surgery.
Surgical procedures performed were as follows: nonan-
atomical liver resection (52%), left hemihepatectomy (34%),
right hemihepatectomy (10%), and left lateral segmentectomy
(3%). Three patients had formal reresection following histo-
logical confirmation of BCA after deroofing of suspected sim-
ple liver cysts. Median length of stay was 7 (IQ 6.5–8.5) days.
Two patients developed postoperative bile leak. One patient
had a low volume bile leak, which was treated conservatively.
The other patient developed bile leak following deroofing of
suspected simple liver cyst and required an endoscopic biliary
stenting to control the high volume bile leak. This patient
subsequently had a formal resection following histological
confirmation of BCA. Two and three patients each developed
wound and chest infection, all of which were treated with
antibiotics. There was no perioperative mortality.
On pathological examination, the median size of the
cyst was 12 (IQ 8.5–18) cm. On histology, 22 patients had
typical ovarian/mesenchymal stroma diagnostic of BCA and
6 patients had no mesenchymal stroma but were positively
stained for mucin. Three patients had features of papillary
tufting (IPNB) with 2 of them also having the presence of
ovarian stroma. Two patients showed calcification in addition
to ovarian stroma. None of these patients had evidence of
malignancy on final histology.
Median follow-up was 13 (IQ 6.5–15.7) years. One patient
developed delayed biliary stricture three years after surgery.
This was initially treated with percutaneous transhep-
atic cholangiogram (PTC) guided dilatation but eventually
required Roux-en-Y hepaticojejunostomy, 7 years from the
primary surgery. None of our patients developed recurrence
of BCA during follow-up. One patient died 11 years later
due to development of inoperable cholangiocarcinoma at a
different site.
5. Discussion
Biliary cystadenomas (BCAs) are potentially malignant, rare
benign cystic lesions of the biliary system of unknown aetiol-
ogy [10, 23]. The incidence of BCA is from one in 20,000 to
100,000 people, while the occurrence of cystadenocarcinoma
is approximately one in 10 million patients [17]. Even though
the previously published literature quoted the incidence of
BCAs to be around 5% of cystic hepatic tumours, the true
incidence is still unclear [12, 15, 24]. The controversy is due
to lack of established criteria for preoperative diagnosis of
unilocular BCAs [6, 12, 14, 16]. Due to its potential for
malignant transformation and tendency to recur, there is a
great concern in treating this tumour with techniques other
than formal resection [3–5].
Aetiology of BCA is unclear and both congenital and
acquired origins have been proposed. Presence of hamar-
tomatous structures supports the theory of congenital origin
[25]. Cruickshank et al. proposed a theory of acquired lesion
and reported the development of BCAs as a reactive process
to focal injury [3, 26]. It was also suggested that this might
have arisen from ectopic embryonal tissue destined to form
gall bladder or from ectopic embryonic rest of primitive
foregut sequestered within the liver [3, 24, 27, 28]. Presence
of endocrine cells in BCAs and cystadenocarcinomas also
suggest the origin from peribiliary glands [29].
Biliary cystadenomas are composed of communicat-
ing variable sized locules usually containing clear fluid.
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The locules are lined by simple, predominantly columnar
epithelium resembling biliary epithelium with cytoplasmic
mucin [23]. Edmondson initially defined BCAs in 1958 as
multilocular lesions with ovarian-like stroma, but subse-
quently BCAs without ovarian stroma were reported [5].
Due to this uncertainty WHO, which initially classified
these lesions as biliary cystadenoma/adenocarcinoma in
2000, redefined these lesions as either mucinous cystic
neoplasm (MCN) or intraductal papillary neoplasm of bile
duct (IPN-B) depending on the presence of ovarian stroma
and papillary growth within the bile duct, respectively [30–
32]. WHO further classified these IPNBs into IPN with
low- or intermediate-grade intraepithelial neoplasia, IPN
with high-grade intraepithelial neoplasia, and IPN with an
associated invasive carcinoma [33]. The majority of biliary
cystadenomas do not communicate with the bile ducts, but
luminal communication may be occasionally observed [34].
The epithelium may show varying degrees of dysplasia.
High-grade dysplasia or invasive carcinoma suggest transfor-
mation to cystadenocarcinoma [23]. Devaney et al. proposed
three subsets of cystadenocarcinoma based on the pathology
material submitted to their institutional laboratories for
primary diagnosis or consultation: (1) cystadenocarcinoma
originating from a benign cystadenoma with ovarian-like
stroma occurs exclusively in women; (2) de novo cystadeno-
carcinoma occurs almost only in men; and (3) cystadenocar-
cinomaoccurs inwomenbut does not contain an ovarian-like
stroma [5].
The development of cystadenocarcinomas is unclear,
whether they are de novo cancers or develop frompreexisting
BCAs. However, it is generally believed that they arise
from BCAs as many cystadenocarcinomas contain areas of
BCAs in the same sample [3, 24, 28, 35]. A malignant
transformation rate of up to 30% has been reported, and
biliary cystadenocarcinoma accounts for 0.41% of malignant
hepatic epithelial tumours [15, 16, 18, 19, 36, 37]. Elements
of BCA were present in 1/3 of biliary cystadenocarcinomas
[5, 24]. Wheeler and Edmondson reported malignant change
in 23% of the resected BCAs [24]. In our study none of
the patients had malignant change in the final histology of
resected BCAs. But there were no case-control or cohort
studies to define the exact risk of malignant transformation
of untreated biliary cystadenoma to cystadenocarcinoma. In
the present study also it is unclear, as our patient developed
cholangiocarcinoma rather than cystadenocarcinoma many
years after the resection of BCA.
Majority of the BCAs present with vague abdominal
complaints secondary to extrinsic compression of stomach,
duodenum, or biliary tree [5, 24, 38]. In our series, about three
quarters of the patients presentedwith vague abdominal pain.
But BCAs have also been identified in asymptomatic patients
during imaging or surgical exploration for unrelated clinical
conditions [39].
Even with improved imaging techniques, it is still chal-
lenging to differentiate BCAs from other cystic lesions of
the liver. Differential diagnosis for BCAs includes simple
liver cysts, parasitic cysts, haematomas or posttraumatic
cysts, liver abscesses, congenital cysts, polycystic disease,
Figure 1: CT scan showing unilocular biliary cystadenoma without
any septations but with calcification in the wall.
Figure 2: MRI picture showing septated biliary cystadenoma with
nodule.
Caroli’s disease, and neoplastic lesions such as biliary cystade-
nocarcinoma, undifferentiated embryonal sarcoma, cystic
metastasis, metastatic pancreatic or ovarian cystadenocarci-
noma, biliary papilloma (IPNB), cystic primary hepatocellu-
lar carcinoma, cystic cholangiocarcinoma, and hepatobiliary
mesenchymal tumours [2, 32, 40, 41].
Ultrasound scan, CT (Figure 1), MRI (Figure 2), MRCP,
ERCP, intraoperative cholangiography, and choledochoscopy
all have been described in the literature for the preoperative
work-up of BCA [42–46]. Preoperative radiological diagnos-
tic accuracymay be as low as 30%, so a high index of suspicion
is required in the diagnosis of BCA [47].
Although radiologic features such as papillary projec-
tions, internal septations, wall thickness, irregularities, and
mural nodules suggest the possibility of a BCA, all of these
except papillary projections may be observed in simple cysts
as well albeit at a lower frequency [48, 49].
Preoperative cyst fluid aspiration for diagnosis has been
advocated in the published literature. Cyst fluid CA19-9
and CEA levels can be helpful to enhance the accuracy
of diagnosis of BCAs and cystadenocarcinomas from other
cystic lesions [10, 17, 50]. However, it is not accurate in dif-
ferentiating BCAs from cystadenocarcinoma, as inadequate
sampling may miss the microscopic foci of carcinoma in a
cystadenoma [50–52]. Preoperative differentiation of BCAs
from cystadenocarcinoma is extremely difficult and can only
be done after pathological examination [1, 3, 24, 28, 39, 41].
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FNA and needle biopsy may risk dissemination of tumour
cells and it is not generally recommended, especially when
surgery is planned [10, 52].
Improper preoperative diagnosis can lead to incorrect
and unnecessary procedures such as percutaneous aspiration,
ethanol injection, deroofing, and omentoplasty [20]. In our
series, 3 patients were diagnosed as simple cysts on imaging
but on histological examination were found to be BCAs.
These patients had second surgical intervention to remove the
lesion with clear margins.
Lewis et al. and Madariaga et al. recommended surgical
resection as the treatment of choice for all multiloculated
hepatic cystic lesions [16, 53]. If BCA is suspected on imaging,
surgery is indicated even if the patient is asymptomatic
[1, 24, 28, 39, 52, 54]. The extent of resection remains to
be determined, as partial resection with occasional ablation
of the residual cyst using electrocautery or argon beam
coagulation and/or omentopexy, lobectomy, wedge resection,
and enucleation have all been reported [16, 17, 28, 29, 55–
57]. Pinson et al. have reported cyst enucleation without
late recurrence and mortality [57]. This procedure is a valid
alternative where resection is difficult or is likely to be
associated with morbidity [10, 14]. In our series, majority of
the patients had nonanatomical liver resections. Patients with
large BCAs and lesions confined to few segments were treated
with formal hepatectomy.
Other limited procedures like aspiration, fenestration,
internal drainage, sclerotherapy, and partial resection are
associated with extremely high recurrence ranging from 90
to 100%, compared to 0 to 10% with formal resection [4, 14,
16, 20, 52, 55, 58–61]. In our series, all of our patients had
formal resection with no recurrence after a median follow-
up of 13 (IQ 6.5–15.7) years. Due to its premalignant nature,
low radiological diagnostic accuracy, and high recurrence
with improper treatment, formal liver resection is recom-
mended.
The prognosis of patients with biliary cystadenoma is
good if total excision of the lesion is performed [3, 5, 14, 20, 24,
52]. In the present study the 10-year survival was 90%. Only
one patient died of late development of cholangiocarcinoma
and 2 other patients died of other causes after 8 and 9 years
following resection, respectively.
We conclude that biliary cystadenomas are rare and can
be resected safely with significantly lowmorbidity. Malignant




MCN: Mucinous cystic neoplasm
IPNB: Intraductal papillary neoplasm of bile duct.
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